Moreover, our results suggested that TAC-induced impairment of hepatic insulin signaling (manifested as decreased levels of GLUT2, IRS2 and pAKT) might cause the insulin resistance observed in patients with NODAT. This evidence concerns the gene INS and Insulin resistance.